Incidence and remission of endometriosis in Germany based on prevalence data from 35 million patients from the statutory health insurance
article
OA: gold
CC0
Abstract
Endometriosis is a chronic gynecological disease that can potentially develop as early as birth and can restrict the life of the patient. With the increasing prevalence of endometriosis in Germany, it has recently gained attention and priority for consideration. While numerous studies have examined endometriosis in Germany and other countries, studies on its incidence and remission rates are rare. Therefore, this study aimed to estimate the incidence and remission rates of endometriosis based on its age-specific prevalence in German women from 2012 to 2022.This study utilized data from the Central Institute (Zi) for Statutory Health Insurance (SHI) in Germany [1], which observed more than 35 million SHI-insured adolescents and women aged ≥ 10 years in 2012 and 2022, to determine the age-specific prevalence of ascertained diagnoses of endometriosis. The Illness-Death Model was used to estimate the incidence and remission rates of endometriosis. The estimation is based on a bootstrapping approach with 5000 replicates-samples. Results are the median incidence and remission rates, reported with 95% confidence intervals (CIs) based on 2.5% and 97.5% percentiles-quantiles, which quantify the uncertainty of the estimated incidence and remission rates.The bootstrapping approach estimated the incidence (median incidence across all bootstrap samples) about 1.73 per 1,000 person-years at around age of 32 years, and the highest remission rate was about 70.04 at the age of 52 years. The estimated 95% (CI) for the incidence and remission rates were (95% CI 1.71-1.78) and (95% CI 68.1-75.0), respectively.The Illness-Death Model and the prevalence of endometriosis from the Zi enabled the incidence rate of ascertained endometriosis for German women to be estimated. This study was the first to estimate the remission rate of endometriosis in Germany, aiming to better understand the condition.
My notes (saved in your browser only)
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (14)
- Diagnosis and Treatment of Endometriosis. Guideline of the DGGG, SGGG and OEGGG (S2k Level, AWMF Registry Number 015/045, August 2020) via openalex
- Incidence and remission of endometriosis in Germany based on prevalence data from 35 million patients from the statutory health insurance via openalex
- Prevalence and incidence of diagnosed endometriosis and risk of endometriosis in patients with endometriosis-related symptoms: findings from a statutory health insurance-based cohort in Germany via openalex
- Prevalence and incidence of endometriosis in Australian women: a data linkage cohort study via openalex
- Prevalence, diagnostic delay and economic burden of endometriosis and its impact on quality of life: results from an Eastern Mediterranean population via openalex
- Temporal and regional differences in the incidence of hospital‐diagnosed endometriosis: a Danish population‐based study via openalex
- W4313279502 via openalex
- W4362664184 via openalex
- W4403894008 via openalex
- W6888597436 via openalex
- W3134885188 via openalex
- W2098400283 via openalex
- W3168961113 via openalex
- W4283583610 via openalex
SciLite annotations
organisms 3
noordeloos 2009062
noordeloos 2009062
noordeloos 2009062
chemicals 1
progestin
Source provenance
- europepmc
- last seen: 2026-07-04T06:08:07.471253+00:00
- openalex
- last seen: 2026-07-04T06:01:59.113452+00:00
- pubmed
- last seen: 2026-07-04T06:03:26.594809+00:00
- scilite
- last seen: 2026-06-28T09:31:30.222730+00:00
License: CC0
· commercial use OK